Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival

There is no consensus on the best donor for children with nonmalignant disorders and immune deficiencies in the absence of a matched related donor (MRD). We evaluated the 2-year overall survival (OS) after umbilical cord blood transplantation (UCBT) in patients with nonmalignant disorders from 2009...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Caridad, Aguayo-Hiraldo, Paibel, Chaimowitz, Natalia, Forbes, Lisa, Rider, Nicholas, Nicholas, Sarah, Seeborg, Filiz, Chinen, Javier, Chinn, Ivan, Davis, Carla, Roseblatt, Howard, Noroski, Lenora, Omer, Bilal, John, Tami, Yassine, Khaled, Naik, Swati, Craddock, John, Bhar, Saleh, Allen, Carl, Ahmed, Nabil, Sasa, Ghadir, Steffin, David, Doherty, Erin, George, Anil, Salem, Baheyeldin, Friend, Brian, Hegde, Meenakshi, Brenner, Malcolm K., Heslop, Helen E., Leen, Ann, Peña, Amanda, Wu, Mengfen, Hanson, I. Celine, Krance, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165184/
https://www.ncbi.nlm.nih.gov/pubmed/36453638
http://dx.doi.org/10.1182/bloodadvances.2022009038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165184/
https://www.ncbi.nlm.nih.gov/pubmed/36453638
http://dx.doi.org/10.1182/bloodadvances.2022009038

Ejemplares similares